Enhabit (NYSE:EHAB – Get Free Report) will issue its quarterly earnings data after the market closes on Wednesday, November 6th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
Enhabit (NYSE:EHAB – Get Free Report) last announced its earnings results on Tuesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.05 by $0.02. The company had revenue of $260.60 million for the quarter, compared to analyst estimates of $265.99 million. Enhabit had a positive return on equity of 1.61% and a negative net margin of 0.84%. During the same period in the prior year, the company posted $0.04 EPS. On average, analysts expect Enhabit to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
Enhabit Price Performance
Shares of NYSE EHAB opened at $7.63 on Tuesday. Enhabit has a fifty-two week low of $6.85 and a fifty-two week high of $11.74. The company has a market cap of $383.66 million, a PE ratio of -44.88 and a beta of 1.84. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.48 and a current ratio of 1.48. The business has a 50-day simple moving average of $7.64 and a two-hundred day simple moving average of $8.62.
Insider Buying and Selling
Enhabit Company Profile
Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.
Featured Stories
- Five stocks we like better than Enhabit
- Most Volatile Stocks, What Investors Need to Know
- Intel: Is Now the Time to Be Brave?Â
- Technology Stocks Explained: Here’s What to Know About Tech
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Enhabit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enhabit and related companies with MarketBeat.com's FREE daily email newsletter.